155 related articles for article (PubMed ID: 18617917)
1. Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth.
Jeudy G; Salvadori F; Chauffert B; Solary E; Vabres P; Chluba J
Cancer Gene Ther; 2008 Nov; 15(11):742-9. PubMed ID: 18617917
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X
Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; Yao H; Zhang W; Wang J; Cao X
J Mol Med (Berl); 2002 Sep; 80(9):585-94. PubMed ID: 12226740
[TBL] [Abstract][Full Text] [Related]
4. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U
Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087
[TBL] [Abstract][Full Text] [Related]
5. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
Wahlsten JL; Mills CD; Ramakrishnan S
J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
[TBL] [Abstract][Full Text] [Related]
6. In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein.
Ma W; Yu H; Wang Q; Bao J; Yan J; Jin H
Cancer Immunol Immunother; 2004 Feb; 53(2):118-24. PubMed ID: 14574492
[TBL] [Abstract][Full Text] [Related]
7. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF
Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254
[TBL] [Abstract][Full Text] [Related]
8. In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.
Duguay D; Mercier F; Stagg J; Martineau D; Bramson J; Servant M; Lin R; Galipeau J; Hiscott J
Cancer Res; 2002 Sep; 62(18):5148-52. PubMed ID: 12234977
[TBL] [Abstract][Full Text] [Related]
9. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
Sundstedt A; Celander M; Hedlund G
Int Immunopharmacol; 2008 Mar; 8(3):442-52. PubMed ID: 18279798
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting non-viral vector based on polyethylenimine improves gene transfer efficiency.
Li D; Tang GP; Li JZ; Kong Y; Huang HL; Min LJ; Zhou J; Shen FP; Wang QQ; Yu H
J Biomater Sci Polym Ed; 2007; 18(5):545-60. PubMed ID: 17550658
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
Li D; Wang QQ; Tang GP; Huang HL; Shen FP; Li JZ; Yu H
J Zhejiang Univ Sci B; 2006 Nov; 7(11):906-11. PubMed ID: 17048306
[TBL] [Abstract][Full Text] [Related]
12. Enhanced thoracic gene delivery by magnetic nanobead-mediated vector.
Li W; Ma N; Ong LL; Kaminski A; Skrabal C; Ugurlucan M; Lorenz P; Gatzen HH; Lützow K; Lendlein A; Pützer BM; Li RK; Steinhoff G
J Gene Med; 2008 Aug; 10(8):897-909. PubMed ID: 18481827
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy by membrane-expressed superantigen for alpha-fetoprotein-producing hepatocellular carcinoma.
Si S; Sun Y; Li Z; Ge W; Zhang X; Hu P; Huang Y; Chen G; Song H; Huang Y; Ma B; Li X; Sui Y
Gene Ther; 2006 Nov; 13(22):1603-10. PubMed ID: 16855617
[TBL] [Abstract][Full Text] [Related]
14. A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma.
Takemura S; Kudo T; Asano R; Suzuki M; Tsumoto K; Sakurai N; Katayose Y; Kodama H; Yoshida H; Ebara S; Saeki H; Imai K; Matsuno S; Kumagai I
Cancer Immunol Immunother; 2002 Mar; 51(1):33-44. PubMed ID: 11845258
[TBL] [Abstract][Full Text] [Related]
15. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector.
Dolivet G; Merlin JL; Barberi-Heyob M; Ramacci C; Erbacher P; Parache RM; Behr JP; Guillemin F
Cancer Gene Ther; 2002 Aug; 9(8):708-14. PubMed ID: 12136433
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes.
Gautam A; Densmore CL; Waldrep JC
Mol Ther; 2000 Oct; 2(4):318-23. PubMed ID: 11020346
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.
Sundstedt A; Celander M; Ohman MW; Forsberg G; Hedlund G
Int Immunopharmacol; 2009 Aug; 9(9):1063-70. PubMed ID: 19410661
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis.
Wang X; Xu M; Zhang H; Liu J; Li X; Zhang C
Cancer Immunol Immunother; 2009 May; 58(5):677-86. PubMed ID: 18818919
[TBL] [Abstract][Full Text] [Related]
19. TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect.
Penafuerte C; Galipeau J
Cancer Immunol Immunother; 2008 Aug; 57(8):1197-206. PubMed ID: 18214474
[TBL] [Abstract][Full Text] [Related]
20. [Expression and bioactivity of the cloned staphylococcal enterotoxin O].
Pan YQ; Ding D; Sun HY; Chen SQ
Yao Xue Xue Bao; 2007 Sep; 42(9):943-8. PubMed ID: 18050735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
